Based on the provided data and technical indicators, here's a comprehensive analysis and price prediction for ABT for the next trading week:
Technical Analysis
Recent News Impact
Price Projection for Next Week Based on Fibonacci levels and technical indicators:
Trading Recommendation BUY with entry around $128-129 range
The stock shows strong technical setup with positive analyst sentiment and institutional support. While insider selling presents some concern, the company's fundamental outlook remains solid with analysts maintaining bullish stance.
The price of ABT is predicted to go up 16.89%, based on the high correlation periods with PGC. The similarity of these two price pattern on the periods is 99.18%.
ABT
PGC
Year
ABT Price Forecast($)
Potential Return(%)
2025
113.930
0.090
2026
145.000
13.340
2027
160.000
25.070
2028
160.000
25.070
2029
175.000
36.790
2030
180.000
40.700
Abbott has been investing in structural heart products and recently entered the left atrial appendage closure market.
Early results from an investigational clinical trial on the Tendyne transcatheter mitral valve were favorable. If the pivotal trial results are favorable, this could give a boost to Abbott's structural heart unit.
Abbott's sale of its established pharma business in developed markets to Mylan and its acquisition of CFR and Veropharm have put the branded generics business in a strong position to benefit from growing demand in emerging markets.
Stifel
2025-01-23
Price Target
$130 → $135
Upside
+10.54%
UBS
2025-01-23
Price Target
$146 → $148
Upside
+21.18%
Barclays
2024-11-05
Price Target
$143 → $149
Upside
+26.74%